Top Markets
#1 Purr Purr +54.31%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 ApeX ApeX +22.22%
#4 Pons Pons +21.14%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +19.69%
#6 Zora Zora +18.56%
#7 Non-Playable Coin Non-Playable Coin +18.52%
#8 龙虾 (Lobster) 龙虾 (Lobster) +17.64%
#9 OriginTrail OriginTrail +17.52%
#10 Pendle Pendle +16.17%
Coin of the day
Purr Purr
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Classement en actions #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Prix de l'action
$2.72
Dernière synchronisation: 2023-10-19
Capitalisation boursière
$111.47M
Changement (1 jour)
-0.73%
Changement (1 an)
0.00%
Pays
US
Échange Talaris Therapeutics, Inc. (TALS)

Catégorie

Healthcare
Le prix TALS avec la capitalisation boursière de B
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
TALS
$2.72
Capitalisation boursière de Talaris Therapeutics, Inc.(TALS)
Capitalisation boursière: $111.47M
En August 2026, Talaris Therapeutics, Inc. a une capitalisation boursière de $111.47M. Cela fait de Talaris Therapeutics, Inc. la 21258th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Talaris Therapeutics, Inc. du 2021 au 2026
TALS par rapport au top 5 des plus populaires stocks
Prix pour TALS L’actif B La capitalisation boursière de B Résultats
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$127,168 $111.47M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,675,210.91%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$110,950 $111.47M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,078,953.24%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$101,573 $111.47M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,734,210.45%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$87,671.72 $111.47M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,223,124.84%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$68,151.57 $111.47M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,505,472.44%